Loading clinical trials...
Loading clinical trials...
Edoxaban Versus Standard of Care and Their Effects on Clinical Outcomes in Patients Having Undergone Transcatheter Aortic Valve Implantation (TAVI) - in Atrial Fibrillation
Conditions
Interventions
Edoxaban-based Regimen
VKA-based Regimen
Locations
230
United States
University of Alabama at Birmingham
Birmingham, Alabama, United States
University of Arizona Sarver Heart Center
Tucson, Arizona, United States
Arkansas Site Management Services
Little Rock, Arkansas, United States
Loma Linda University Medical Center
Loma Linda, California, United States
Cedar-Sinai Heart Institute
Los Angeles, California, United States
UCLA Cardiovascular Center
Los Angeles, California, United States
Start Date
March 21, 2017
Primary Completion Date
February 28, 2021
Completion Date
February 28, 2021
Last Updated
March 24, 2022
NCT05147792
NCT06935591
NCT05963698
NCT03546374
NCT04947657
NCT06686485
Lead Sponsor
Daiichi Sankyo
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions